首页 › 急性髓系白血病 › 康涅狄格州 › Bridgeport
Bridgeport CT 急性髓系白血病临床试验
12项针对 急性髓系白血病的研究正在 Bridgeport及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
招募中2 期
- Stony Brook University Medical Center, Stony Brook · 距离 18 英里
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Stony Brook University Medical Center, Stony Brook · 距离 18 英里
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
招募中2 期
- Stony Brook University Medical Center, Stony Brook · 距离 18 英里
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
招募中2 期
- Stony Brook University Medical Center, Stony Brook · 距离 18 英里
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
招募中2 期
- Stony Brook University Medical Center, Stony Brook · 距离 18 英里
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
招募中2 期
- Stony Brook University Medical Center, Stony Brook · 距离 18 英里
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
招募中3 期
- Stony Brook University Medical Center, Stony Brook · 距离 18 英里
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Stony Brook University Medical Center, Stony Brook · 距离 18 英里
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
招募中1 期
- Stony Brook Cancer Center, Stony Brook · 距离 18 英里
Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)
招募中观察性研究
- Stony Brook Cancer Center, Stony Brook · 距离 18 英里
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中观察性研究
- Stony Brook University Hospital, Stony Brook · 距离 18 英里
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
招募中1 期
- Stony Brook University Hospital, Stony Brook · 距离 18 英里
其他城市的 急性髓系白血病试验
- Houston, TX85 项研究
- New York City, NY51 项研究
- Boston, MA44 项研究
- Seattle, WA41 项研究
- Baldwin Park, CA40 项研究
- Columbus, OH35 项研究
- Philadelphia, PA34 项研究
- Durham, NC33 项研究
- Atlanta, GA31 项研究
- Tampa, FL29 项研究
- Chicago, IL26 项研究
- Portland, OR25 项研究
Bridgeport的其他研究
- 乳腺癌21 项研究
- 非小细胞肺癌14 项研究
- 肺癌13 项研究
- 心血管疾病9 项研究
- 癌症（所有类型）8 项研究
- 头颈鳞状细胞癌8 项研究
- 转移性癌症7 项研究
- 心力衰竭7 项研究
- 脑动脉瘤6 项研究
- 多发性骨髓瘤6 项研究
- 前列腺癌6 项研究
- 卵巢癌5 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。